Bayer HealthCare LLC is the latest pharmaceutical firm to expand in the dietary supplement space with the acquisition of Schiff Nutrition International Inc. for $1.2 billion, or roughly $34 per share, in a deal the German firm announced Oct. 30.
“This acquisition will strengthen Bayer’s leading OTC business and complement our existing nutritionals business with well-established, strong brands,” said